Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Treasury Shares (2019 - 2023)

Historic Treasury Shares for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$541000.0.

  • ADC Therapeutics' Treasury Shares fell 43564.36% to -$541000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$541000.0, marking a year-over-year decrease of 43564.36%. This contributed to the annual value of $679000.0 for FY2022, which is 53056875.0% up from last year.
  • Latest data reveals that ADC Therapeutics reported Treasury Shares of $6.8 million as of Q3 2023.
  • Over the past 5 years, ADC Therapeutics' Treasury Shares peaked at $8.4 million during Q4 2022, and registered a low of $1.6 million during Q4 2021.
  • Moreover, its 3-year median value for Treasury Shares was $7.0 million (2023), whereas its average is $6.4 million.
  • As far as peak fluctuations go, ADC Therapeutics' Treasury Shares crashed by 334990000.0% in 2021, and later surged by 63621.36% in 2022.
  • Quarter analysis of 5 years shows ADC Therapeutics' Treasury Shares stood at -$100.0 in 2019, then surged by 96.0% to -$4.0 in 2020, then crashed by 3165615.89% to -$126628.6 in 2021, then surged by 636.21% to $679000.0 in 2022, then plummeted by 179.68% to -$541000.0 in 2023.
  • Its Treasury Shares was -$541000.0 in Q3 2023, compared to -$557000.0 in Q2 2023 and -$645000.0 in Q1 2023.